Fragment-based drug design

Over the last twenty years fragment-based drug design (FBDD) has emerged as one of the most prominent strategies used to identify innovative drug discovery Hits. FBDD presumes drug molecules are made of a combination of small fragments, each contributing to the a nity of the drug for its biological target. Unlike HTS, which aims to identify moderate to high a nity Hits the size of a typical drug molecule, fragment screening scouts for small molecule Hits with weaker but leaner a nity to their biological target. The FDBB strategy had led to many drug discovery successes including 4 approved drugs and another 40 under clinical investigation. At Concept Life Sciences, our FBDD service is designed to enhance success rate and speed of delivery.

Connexion

Not registered yet? Create an account